Paternostre et al., 1997 - Google Patents
Solubilization and reconstitution of vesicular stomatitis virus envelope using octylglucosidePaternostre et al., 1997
View PDF- Document ID
- 7213208541944996416
- Author
- Paternostre M
- Viard M
- Meyer O
- Ghanam M
- Ollivon M
- Blumenthal R
- Publication year
- Publication venue
- Biophysical journal
External Links
Snippet
Reconstituted vesicular stomatitis virus envelopes or virosomes are formed by detergent removal from solubilized intact virus. We have monitored the solubilization process of the intact vesicular stomatitis virus by the nonionic surfactant octylglucoside at various initial …
- 241000711975 Vesicular stomatitis virus 0 title abstract description 90
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48792—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a colloid, emulsion, i.e. having at least a dispersed/continuous oil phase and a dispersed/continuous aqueous phase, dispersion or suspension
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Paternostre et al. | Solubilization and reconstitution of vesicular stomatitis virus envelope using octylglucoside | |
Stegmann et al. | Functional reconstitution of influenza virus envelopes. | |
van Meer et al. | The function of tight junctions in maintaining differences in lipid composition between the apical and the basolateral cell surface domains of MDCK cells. | |
Bron et al. | [23] Preparation, properties, and applications of reconstituted influenza virus envelopes (virosomes) | |
Maeda et al. | Spin-label study on fusion of red blood cells induced by hemagglutinating virus of Japan | |
Helenius et al. | On the entry of Semliki forest virus into BHK-21 cells | |
van Meer et al. | The tight junction does not allow lipid molecules to diffuse from one epithelial cell to the next | |
Fenart et al. | Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier | |
Schlegel et al. | Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV-binding site? | |
Anwekar et al. | Liposome-as drug carriers. | |
Günther-Ausborn et al. | Inhibition of influenza-induced membrane fusion by lysophosphatidylcholine | |
Sefton et al. | Effect of the viral proteins on the fluidity of the membrane lipids in Sindbis virus | |
Hsu et al. | Fusion of Sendai virus with liposomes: Dependence on the viral fusion protein (F) and the lipid composition of liposomes | |
Citovsky et al. | Fusion of Sendai virions with phosphatidylcholine-cholesterol liposomes reflects the viral activity required for fusion with biological membranes | |
Nussbaum et al. | Reconstitution of functional influenza virus envelopes and fusion with membranes and liposomes lacking virus receptors | |
Citovsky et al. | Fusion of Sendai virions or reconstituted Sendai virus envelopes with liposomes or erythrocyte membranes lacking virus receptors. | |
Harmsen et al. | Reconstitution and fusogenic properties of Sendai virus envelopes | |
Günther-Ausborn et al. | Role of hemagglutinin surface density in the initial stages of influenza virus fusion: lack of evidence for cooperativity | |
Scheule | Novel preparation of functional Sindbis virosomes | |
Chejanovsky et al. | Membrane vesicles containing the Sendai virus binding glycoprotein, but not the viral fusion protein, fuse with phosphatidylserine liposomes at low pH | |
Stebelska et al. | The effect of PS content on the ability of natural membranes to fuse with positively charged liposomes and lipoplexes | |
Shoji et al. | Preparation of virosomes coated with the vesicular stomatitis virus glycoprotein as efficient gene transfer vehicles for animal cells | |
Schoen et al. | Delivery of foreign substances to cells mediated by fusion-active reconstituted influenza virus envelopes (virosomes) | |
Ellens et al. | Delivery of macromolecules into cells expressing a viral membrane fusion protein | |
Walter et al. | Functional reconstitution of viral envelopes |